nipolazin
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Histamine H1 receptorANTAGONIST
Histamine H1 receptor antagonist
Chemistry & pharmacology
Loading structure…
SMILES
c1ccc2c(c1)Sc1ccccc1N2CC12CCN(CC1)CC2- Mol. weight
- 322.48 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL73451 ↗
- ChEMBLCHEMBL1908311 ↗
Also known as
- 10-(1-azabicyclo(2.2.2)oct-8-ylmethyl)phenothiazine
- 3-methylquinuclidinyl-10-phenothiazine
- kitazemin
- kitazemin
- lm 209
- mequitazina
- mequitazina
- mequitazine
- mequitazine
- mequitazine
- mequitazine
- mequitazine
- mequitazine
- mequitazine
- mequitazine hydrochloride
- mequitazine tartrate, (r-(r*,r*))-isomer
- mequitazinum
- mequitazinum
- metaplexan
- mircol
- nipolazin
- primalan
- primalan
- primalan
- quitadrill